Galen Partners Backs Nautilus Neurosciences

Nautilus Neurosciences Inc., a Bridgewater, N.J.-based drug developer focused on neurology, has raised an undisclosed amount of equity funding from Galen Partners. It previously raised over $14 million from investors that included Tailwind Capital Partners.

North AmericaUSBriefs